Anaphylatic shock after aprotinin reexposure: Time course of aprotinin-specific antibodies

Annals of Thoracic Surgery

Volumn 63, Issue 1, 1997, Pages 242-244

  Scheule, Albertus M ^a   Jurmann, Michael J ^a   Wendel, Hans P ^a   Häberle, Leo ^b   Eckstein, Friedrich S ^a   Ziemer, Gerhard ^a  

^a Division of Thoracic   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; DRUG ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; ANTIBODY; HEMOSTATIC AGENT;

AGED; ANAPHYLACTIC SHOCK; ARTICLE; CASE REPORT; CLINICAL TRIAL; FEMALE; HUMAN; MITRAL VALVE REGURGITATION; PRIORITY JOURNAL; ANAPHYLAXIS; CHEMICALLY INDUCED DISORDER; HEART VALVE PROSTHESIS; IMMUNOLOGY; PEROPERATIVE COMPLICATION; TIME;

AGED; ANAPHYLAXIS; ANTIBODIES; APROTININ; FEMALE; HEART VALVE PROSTHESIS; HEMOSTATICS; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTRAOPERATIVE COMPLICATIONS; TIME FACTORS;

EID: 0030614406     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(96)01062-4     Document Type: Article

References (5)

1. Bidstrup BP, Harrison J, Royston D, Taylor KM, Treasure T. Aprotinin therapy in cardiac operations a report on use in 41 cardiac centers in the United Kingdom . Ann Thorac Surg. 55:1993;971-976.
2. Goldstein DJ, Seldomridge JA, Chen JM, et al. Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality. Ann Thorac Surg. 59:1995;1063-1068.
3. Schulze K, Graeter T, Schaps D, Hausen B. Severe anaphylactic shock due to repeated application of aprotinin in patients following intrathoracic aortic replacement. Eur J Cardiothorac Surg. 7:1993;495-496.
4. Freeman JG, Turner GA, Venables CW, Latner AL. Serial use of aprotinin and incidence of allergic reactions. Curr Med Res Opin. 8:1983;559-561.
5. Brostoff J, Hall T. Hypersensitivity-TypI. Roitt IM, Brostoff J, Male DK. Immunology. 1996;22 Mosby, London.